Nausea
Sensitivity to light, sound, fatigue, neck pain most common prodromal headache symptoms
SAN DIEGO — In a small cohort of adults with headache, the most common prodromal symptoms were light and sound sensitivity, fatigue and neck pain, according to research presented at the American Headache Society Annual Scientific Meeting.
Tips for talking with patients about cannabis use in pregnancy
SAN FRANCISCO — With rising rates of cannabis use and changing legalization throughout the United States, more and more patients and physicians have questions about cannabis use before, during and after pregnancy.
Study questions practice of routine fasting before cardiac catheterization
Patients not required to fast before cardiac catheterization reported higher overall postprocedural satisfaction with no periprocedural adverse events, a speaker reported.
Q&A: First responders need to be trained in how women present with heart attack
Too often, heart attack signals are missed or misdiagnosed in women, not just by patients and providers, but by first responders as well.
Q&A: Endometriosis impact on GI function remains ‘vastly understudied, underrecognized’
Women with endometriosis had higher rates of health care utilization and were significantly more likely to experience upper gastrointestinal and dyspeptic symptoms, according to preliminary data in Clinical Gastroenterology and Hepatology.
Q&A: Misconceptions, risk factors, treatment for nausea, vomiting of pregnancy
Nausea and vomiting of pregnancy, commonly called morning sickness, is a complex condition that can occur at any time of the day and includes and combination of nausea, vomiting and retching.
Tradipitant achieves ‘clinically meaningful outcomes’ in gastroparesis
Although neurokinin-1 receptor antagonist tradipitant did not outperform placebo in improving nausea severity at 12 weeks in patients with gastroparesis, those with adequate tradipitant exposure did achieve overall symptom improvement.
Investigational monthly obesity drug led to durable weight loss in phase 1 trial
Adults with obesity who received an injectable GIP receptor antagonist/GLP-1 receptor agonist every 4 weeks had a decrease in body weight that was maintained for up to 150 days, according to study findings published in Nature Metabolism.
Game helps older adults be 'proactive' to prevent chemotherapy-associated nausea, vomiting
Researchers at University of Central Florda developed an educational game to help older adults with cancer manage chemotherapy-related nausea and vomiting.